EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

Nanoparticle-Based Delivery Systems for Synergistic Therapy in Lung Cancers

Zicheng Deng iD, Ali Al Siraj, Isabella Lowry, Ellen Ruan iD, Rohan Patel, Wen Gao iD, Tanya V Kalin iD, Vladimir V Kalinichenko

Bioengineering · 09.09.2025 · 12 (9) · 968

DOI: 10.3390/bioengineering12090968 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Bioengineering, online erschienen am 09.09.2025. Verfasst von Zicheng Deng und 7 weiteren Autor:innen. Beteiligte Einrichtung: Phoenix Children's Research Institute, Department of Child Health, University of Arizona College of Medicine-Phoenix, Phoenix, AZ 85004, USA. Die Arbeit wurde bisher 13-mal zitiert (Crossref) und nennt 134 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NHLBI NIH HHS.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Lung cancer remains the leading cause of cancer-related mortality worldwide, with conventional treatments often limited by systemic toxicity, different tumor sensitivity to the drugs, and the emergence of multidrug resistance. To address these challenges, nanoparticle-based delivery systems have emerged as an innovative strategy, enabling the simultaneous transport of multiple agents, including chemotherapeutic drugs and expression vectors, to enhance treatment efficacy and overcome tumor resistance. This review explores various nanocarrier platforms, such as liposomes, solid lipid nanoparticles, polymeric micelles, and inorganic nanoparticles, specifically designed for lung cancer therapy. Synergistic effects and physicochemical properties of therapeutic agents must be carefully considered in the design of nanoparticle-based co-delivery systems for lung cancer therapy. We highlight the applications of these nanoparticle systems in drug–drug, gene–gene, and drug–gene co-delivery approaches. By addressing the limitations of traditional therapies, nanoparticle-based systems offer a promising avenue to improve outcomes in patients with lung cancers.

Schlagwörter

Stichwörter der Autor:innen

drug deliverydrug resistancegene therapylung cancernanoparticlesynergistic therapy

Autor:innen und Institutionen

  • Phoenix Children's Research Institute, Department of Child Health, University of Arizona College of Medicine-Phoenix, Phoenix, AZ 85004, USA.
  • School of Life Sciences, College of Liberal Arts & Sciences, Arizona State University, Tempe, AZ 85281, USA.
  • Arizona College of Osteopathic Medicine, Midwestern University, Glendale, AZ 85308, USA.
  • Phoenix Children's Center for Cancer and Blood Disorders, Phoenix Children's Hospital, Phoenix, AZ 85016, USA.
  • Division of Hematology and Oncology, Department of Child Health, University of Arizona College of Medicine-Phoenix, Phoenix, AZ 85004, USA.
  • Division of Neonatology, Phoenix Children's Hospital, Phoenix, AZ 85016, USA.

ORCID-Profile: Zicheng Deng, Ellen Ruan, Wen Gao, Tanya V Kalin

Förderung

  • NHLBI NIH HHS

Zitieren

APA

Deng, Z., Siraj, A. A., Lowry, I., Ruan, E., Patel, R., Gao, W., Kalin, T. V., & Kalinichenko, V. V. (2025). Nanoparticle-Based Delivery Systems for Synergistic Therapy in Lung Cancers. Bioengineering, 12(9), 968. https://doi.org/10.3390/bioengineering12090968

Vancouver

Deng Z, Siraj AA, Lowry I, Ruan E, Patel R, Gao W, et al. Nanoparticle-Based Delivery Systems for Synergistic Therapy in Lung Cancers. Bioengineering. 2025;12(9):968. doi:10.3390/bioengineering12090968

BibTeX
@article{Deng2025,
  author = {Deng, Zicheng and Siraj, Ali Al and Lowry, Isabella and Ruan, Ellen and Patel, Rohan and Gao, Wen and Kalin, Tanya V and Kalinichenko, Vladimir V},
  title = {Nanoparticle-Based Delivery Systems for Synergistic Therapy in Lung Cancers},
  journal = {Bioengineering},
  year = {2025},
  volume = {12},
  number = {9},
  pages = {968},
  doi = {10.3390/bioengineering12090968}
}
Kostenlos starten →